Bhad Bhabie was diagnosed with Hodgkin lymphoma in 2022

Bhad Bhabie, the rapper and social media personality whose real name is Danielle Bregoli, announced in March 2022 that she had been diagnosed with Hodgkin lymphoma, a cancer of the lymph nodes. She shared the diagnosis publicly on social media and later in interviews, saying she had been undergoing chemotherapy treatment.

Hodgkin lymphoma is a blood cancer that starts in white blood cells called lymphocytes. It spreads through the lymph system, which is part of the immune system. The disease can occur at any age but is most common in people in their 20s and in people over 55.

Bhabie reported in late 2022 that she had completed her chemotherapy treatment and that scans showed no evidence of disease. She has continued to work and maintain her public presence since finishing treatment.

Key Takeaways

  • Bhad Bhabie was diagnosed with Hodgkin lymphoma, a cancer affecting lymph nodes and white blood cells.
  • She underwent chemotherapy as her primary treatment starting in 2022.
  • She reported completing treatment and achieving remission by late 2022.
  • Hodgkin lymphoma has different outcomes depending on the stage at diagnosis and the person's age and overall health.

What Hodgkin lymphoma is and how it develops

Hodgkin lymphoma begins when lymphocytes (a type of white blood cell) become abnormal and multiply uncontrollably. These cancer cells collect in the lymph nodes—small bean-shaped organs throughout the body that are part of the immune system. The cancer can spread to other lymph nodes and eventually to other organs.

The disease is different from non-Hodgkin lymphoma, which is a larger group of lymphomas that develop differently and may behave differently. Doctors can tell the difference through a biopsy, where they remove a small sample of tissue to examine under a microscope.

Risk factors for Hodgkin lymphoma include a weakened immune system, certain infections (particularly Epstein-Barr virus), and family history, though most people diagnosed have no known risk factors.

How Hodgkin lymphoma is treated

The main treatments for Hodgkin lymphoma are chemotherapy, radiation therapy, or a combination of both. Chemotherapy uses drugs to kill cancer cells throughout the body. Radiation therapy uses high-energy beams to target cancer cells in specific areas.

The specific treatment plan depends on the stage of the cancer (how far it has spread), the person's age, and their overall health. Early-stage Hodgkin lymphoma often has better outcomes than advanced stages. Bhabie underwent chemotherapy, which is a standard first-line treatment.

Some newer treatments, called targeted therapies and immunotherapies, are also used in certain cases. These drugs work differently than traditional chemotherapy and may be used alone or combined with other treatments.

Survival rates and long-term outlook

Hodgkin lymphoma has one of the highest survival rates among cancers. The five-year survival rate (the percentage of people alive five years after diagnosis) varies by stage but is generally between 85% and 95% overall in the United States. Younger people and those diagnosed at earlier stages typically have better outcomes.

Many people treated for Hodgkin lymphoma go into remission, meaning scans show no evidence of disease. Remission can last for years or indefinitely. Some people may experience a recurrence, where the cancer returns, but treatment options exist for recurrent disease.

Long-term survivors may experience side effects from treatment, including heart problems, lung problems, or secondary cancers years later. Regular follow-up care with an oncologist helps monitor for these potential complications.

What happens during and after chemotherapy

Chemotherapy for Hodgkin lymphoma is typically given in cycles over several months. Each cycle usually lasts a few weeks, with treatment days followed by recovery time. The exact schedule depends on the specific drugs used and the treatment protocol.

During chemotherapy, patients often experience side effects including nausea, fatigue, hair loss, and increased infection risk due to low white blood cell counts. These side effects are usually temporary and improve after treatment ends. Doctors manage side effects with additional medications and supportive care.

After chemotherapy is complete, patients have follow-up scans (usually PET or CT scans) to check whether the cancer has responded to treatment. If scans show no evidence of disease, the person enters a monitoring phase with regular check-ups and imaging to watch for recurrence.

The difference between remission and cure

Remission means that scans and blood tests show no evidence of cancer, but doctors typically avoid using the word "cure" for Hodgkin lymphoma because there is always a small possibility of recurrence. However, many people treated for Hodgkin lymphoma live long, healthy lives without the cancer returning.

The longer someone remains in remission, the lower the risk of recurrence becomes. People who are in remission five years after diagnosis have a significantly lower risk of the cancer returning compared to the first year after treatment.

Frequently Asked Questions

Is Hodgkin lymphoma hereditary?

Hodgkin lymphoma is not inherited, meaning you cannot catch it from a family member or pass it to your children. However, having a family member with Hodgkin lymphoma may slightly increase your risk. Most people diagnosed have no family history of the disease.

Can Hodgkin lymphoma come back after remission?

Yes, recurrence is possible, though it becomes less likely the longer someone stays in remission. If Hodgkin lymphoma does return, treatment options exist, including different chemotherapy drugs, radiation, or newer targeted therapies. Doctors monitor patients closely during follow-up care to catch any recurrence early.

What causes Hodgkin lymphoma?

The exact cause of Hodgkin lymphoma is not fully understood. Certain factors increase risk, including Epstein-Barr virus infection, a weakened immune system, and age. Most people with risk factors never develop the disease, and many people without known risk factors do.

How is Hodgkin lymphoma different from other cancers?

Hodgkin lymphoma is a blood cancer that affects lymph nodes and white blood cells, unlike solid tumors like breast or lung cancer. It spreads through the lymph system rather than forming a single mass. It also has higher survival rates than many other cancer types when treated early.